TNBC is an aggressive, heterogeneous subtype of breast cancer, immunohistochemically negative for estrogen receptor α (ER−) and progesterone receptor (PR−), as well as lacking amplification of the human epidermal growth factor receptor 2 locus (HER2−). Here, PGR is linked to breast carcinoma.